Detalhe da pesquisa
1.
Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Br J Dermatol;
190(6): 836-845, 2024 May 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38470171
2.
Skin, Autoimmunity and Inflammation: A Comprehensive Exploration through Scientific Research.
Int J Mol Sci;
24(21)2023 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37958840
3.
Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review.
Int J Mol Sci;
24(15)2023 Aug 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37569757
4.
miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review.
Int J Mol Sci;
24(10)2023 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37239847
5.
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.
Int J Mol Sci;
24(9)2023 May 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37176138
6.
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.
Int J Mol Sci;
24(5)2023 Mar 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36902341
7.
CT Patterns of Interstitial Lung Disease in Patients with Plaque Psoriasis: A Retrospective Case Series Study.
Medicina (Kaunas);
59(9)2023 Sep 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37763769
8.
Latest combination therapies in psoriasis: Narrative review of the literature.
Dermatol Ther;
35(10): e15759, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35959523
9.
Should we be concerned about gastrointestinal-related adverse events in patients with plaque psoriasis receiving secukinumab therapy? A retrospective, real-life study.
Dermatol Ther;
35(11): e15794, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36038514
10.
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study.
Dermatol Ther;
35(6): e15439, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35278025
11.
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study.
Dermatol Ther;
35(1): e15166, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34676662
12.
Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives.
Int J Mol Sci;
23(19)2022 Sep 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36232430
13.
Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma.
Int J Mol Sci;
24(1)2022 Dec 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36613587
14.
Mesenchymal Stem Cells and Psoriasis: Systematic Review.
Int J Mol Sci;
23(23)2022 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36499401
15.
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma.
Int J Mol Sci;
23(9)2022 Apr 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35563166
16.
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness.
Eur J Clin Invest;
51(5): e13452, 2021 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33210737
17.
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry.
Allergy;
76(6): 1813-1824, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34152613
18.
The efficacy of in vivo administration of Apremilast on mesenchymal stem cells derived from psoriatic patients.
Inflamm Res;
70(1): 79-87, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33210178
19.
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients.
J Am Acad Dermatol;
84(5): 1356-1363, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33476725
20.
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience.
Dermatol Ther;
34(6): e15179, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34704350